Efficacy and safety of Chinese medicine compound for the convalescent COVID-19 patients: Protocol of a multi-centered, randomized, double-blinded, placebo-controlled clinical trial
Rui Fang(German Cancer Research Center), Jinwen Ge(Hunan University of Traditional Chinese Medicine), Qing Chen(Queensland University of Technology), Yunhua Luo(University of Manitoba), Shasha Zhou(North West Agriculture and Forestry University), Yanmei Peng(Chinese Academy of Tropical Agricultural Sciences), Danhong Liu(Hunan Academy of Traditional Chinese Medicine), Dahua Wu(Hunan Academy of Traditional Chinese Medicine), Le Xie(Nankai University), Lei Zhao(Hunan University), Yue Zhou(Hunan University of Traditional Chinese Medicine)
Cited by 0
Related Papers
Exogenous melatonin improved potassium content in <i>Malus</i> under different stress conditions
|Journal of Pineal Research|2016|145
Chinese visceral adiposity index: A reliable indicator of visceral fat function associated with risk of type 2 diabetes
|Diabetes/Metabolism Research and Reviews|2020|107
Design, synthesis, and evaluation of novel fluoroquinolone–flavonoid hybrids as potent antibiotics against drug-resistant microorganisms
|European Journal of Medicinal Chemistry|2014|98
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression
|Nature Communications|2022|94